Education
About Us
Working with TipRanks
Follow Us
Kingworld Medicines Group Ltd. (HK:1110)
:1110
1110 Stock Chart & Stats
HK$0.54
>-HK$0.01(-1.12%)
At close: 4:00 PM EST
HK$0.54
>-HK$0.01(-1.12%)
Day’s Range― - ―
52-Week RangeHK$0.39 - HK$0.64
Previous CloseN/A
Volume780.00K
Average Volume (3M)1.11M
Market Cap
HK$327.51M
Enterprise ValueHK$603.23M
Total Cash (Recent Filing)HK$254.85M
Total Debt (Recent Filing)HK$434.48M
Price to Earnings (P/E)55.1
Beta0.32
Next Earnings
Mar 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield5.87%
Share Statistics
EPS (TTM)-0.01
Shares Outstanding622,499,940
10 Day Avg. Volume874,800
30 Day Avg. Volume1,111,766
Financial Highlights & Ratios
PEG Ratio0.49
Price to Book (P/B)0.38
Price to Sales (P/S)0.23
P/FCF Ratio2.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Kingworld Medicines Group Ltd. News
1110 FAQ
What was Kingworld Medicines Group Ltd.’s price range in the past 12 months?
Kingworld Medicines Group Ltd. lowest stock price was HK$0.39 and its highest was HK$0.64 in the past 12 months.
What is Kingworld Medicines Group Ltd.’s market cap?
Kingworld Medicines Group Ltd.’s market cap is HK$327.51M.
When is Kingworld Medicines Group Ltd.’s upcoming earnings report date?
Kingworld Medicines Group Ltd.’s upcoming earnings report date is Mar 31, 2026 which is in 99 days.
How were Kingworld Medicines Group Ltd.’s earnings last quarter?
Kingworld Medicines Group Ltd. released its earnings results on Aug 27, 2025. The company reported -HK$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.01.
Is Kingworld Medicines Group Ltd. overvalued?
According to Wall Street analysts Kingworld Medicines Group Ltd.’s price is currently Overvalued.
Does Kingworld Medicines Group Ltd. pay dividends?
Kingworld Medicines Group Ltd. pays a Annually dividend of HK$0.032 which represents an annual dividend yield of 5.87%. See more information on Kingworld Medicines Group Ltd. dividends here
What is Kingworld Medicines Group Ltd.’s EPS estimate?
Kingworld Medicines Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kingworld Medicines Group Ltd. have?
Kingworld Medicines Group Ltd. has 622,499,940 shares outstanding.
What happened to Kingworld Medicines Group Ltd.’s price movement after its last earnings report?
Kingworld Medicines Group Ltd. reported an EPS of -HK$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.613%.
Which hedge fund is a major shareholder of Kingworld Medicines Group Ltd.?
Currently, no hedge funds are holding shares in HK:1110
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kingworld Medicines Group Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.19%
12-Months-Change
Fundamentals
Return on Equity
0.86%
Trailing 12-Months
Asset Growth
-5.56%
Trailing 12-Months
Company Description
Kingworld Medicines Group Ltd.
Kingworld Medicines Group Limited, an investment holding company, distributes branded imported pharmaceutical and healthcare products. The company also supplies pharmaceutical, healthcare, general foodstuffs, and medical products. It offers products for various functional categories, such as cough and phlegm relieving, gastrointestinal, vitamin, orthopedics, cardiovascular, influenza, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kawai Product Range, Flying Eagle Wood Lok Medicated Oil, Kyushin Pill, and Mentholatum Product Range brands. The company also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices. It serves in the People's Republic of China, Hong Kong, the United States, the United Kingdom, Germany, Italy, Spain, Mexico, and internationally. The company was founded in 1996 and is headquartered in Shenzhen, the People's Republic of China.
Technical Analysis
Tianda Pharmaceuticals Ltd.
―
Modern Chinese Medicine Group Co. Ltd.
―
Fusen Pharmaceutical Co., Ltd.
―
Tycoon Group Holdings Limited
―
Sinco Pharmaceuticals Holdings Ltd.
―